Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential BCMA/GPRC5D CAR-T in R/R Multiple Myeloma
NCT07032129Phase 2Recruiting
- Sponsor
- Essen BioTech
- Start
- Apr 2025
- Primary completion
- Dec 2027
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of BCMA CAR-T cells + GPRC5D CAR-T cells in multiple myeloma (MM), sponsored by Essen BioTech. Started Apr 2025; status: recruiting.
02
Drugs
BCMA CAR-T cells + GPRC5D CAR-T cells
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT07032129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07032129.